KIDS Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
70.5M
+18.8%
59.4M
-3.6%
61.6M
+0.6%
61.3M
+0.3%
61.1M
Cost of Revenue
18.1M
+13.6%
16.0M
-3.2%
16.5M
+3.3%
16.0M
-6.4%
17.1M
Gross Profit
52.4M
+20.7%
43.4M
-3.8%
45.1M
-0.4%
45.3M
+2.9%
44.0M
Operating Expenses
56.4M
+9.1%
51.7M
-2.9%
53.3M
-2.6%
54.7M
+0.0%
54.7M
R&D
2.3M
+4.2%
2.2M
-1.2%
2.3M
-3.2%
2.3M
+8.1%
2.2M
SG&A
54.1M
+9.3%
49.5M
+2.4%
48.4M
+1.1%
47.8M
-3.5%
49.5M
Operating Income
-4068000
+51.2%
-8335000
-2.0%
-8172000
+13.3%
-9428000
+11.5%
-10657000
EBITDA
1.6M
+162.7%
-2614000
-2822.9%
96.0K
-77.8%
433.0K
+117.2%
-2516000
Net Income
-7163000
+33.0%
-10687000
-5.8%
-10103000
+14.2%
-11773000
-65.5%
-7113000
EPS (Basic)
$-0.30
+33.3%
$-0.45
-4.7%
$-0.43
+14.0%
$-0.50
-66.7%
$-0.30
EPS (Diluted)
$-0.30
+33.3%
$-0.45
-4.7%
$-0.43
+14.0%
$-0.50
-66.7%
$-0.30
Shares (Diluted)
24.0M
+1.5%
23.7M
+0.4%
23.6M
+0.1%
23.6M
+0.5%
23.5M
OrthoPediatrics (KIDS) โ€” Financials